期刊
JOURNAL OF RHEUMATOLOGY
卷 42, 期 1, 页码 55-59出版社
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.140367
关键词
AUTOIMMUNE DISEASES; AROMATASE INHIBITORS; SYSTEMIC LUPUS ERYTHEMATOSUS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; ESTROGEN RECEPTOR-POSITIVE; RHEUMATOID ARTHRITIS
类别
Objective. To investigate the relationship between antiestrogen therapy in women with breast cancer and risk of autoimmune disease. Methods. We used a national database to assess the incidence of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) following treatment with selective estrogen receptor modulators (SERM) or aromatase inhibitors (AI) in women with breast cancer. The total number of patients in our study was 190,620. Results. We observed highly significant, cumulative dose-dependent increased OR of incidence of both SLE and RA following treatment with SERM (p < 0.0001). The odds of developing RA were also increased following AI therapy (p < 0.001), but there was a trend for reduced odds of SLE, though this trend did not attain statistical significance (p = 0.070 for 2-11 months of treatment and p = 0.254 for 12+ months of treatment). Conclusion. Antiestrogen agents may have an important effect on risk of autoimmune disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据